Sentences with phrase «week sof»

Steven, Daniel and Troy cover the last two week sof various Nintendo goings - on, along with some discussion around Switch games being more expensive than the same game on other p...

Not exact matches

Just over a week before the deadline with SOF, American Apparel found a white knight: Lion Capital, a private - equity group in London, that invested US$ 80 million.
Results presented today at The International Liver Congress ™ 2015 demonstrate that hepatitis C (HCV)- infected genotype - 3 (GT - 3) patients, with and without cirrhosis, receiving 24 weeks of sofosbuvir (SOF) in combination with ribavirin (RBV) and peginterferon (PEG) achieved the highest sustained virologic response rates at 12 weeks (SVR12), observed in a Phase 3 study, to date.
The 12 - week combination of SOF / DCV / RBV achieved a 100 % SVR4 rate in cirrhotic patients without the additive effect of extension of the treatment to 24 weeks with or without RBV (95.7 % and 92.5 %, respectively), and this was also true in experienced patients.
All non-cirrhotic patients achieved 100 % SVR4 at 12 weeks, demonstrating that the 12 - week combination of SOF / DCV is a proven therapeutic option.
Overall, the sustained virologic response rate at 4 weeks (SVR4) for SOF / DCV was 81.6 % after 12 weeks of treatment and 93.9 % following 24 weeks of treatment.
A study presented today that evaluated an investigational dosage of once - daily ledipasvir 45 mg / sofosbuvir 200 mg (LDV / SOF) in children aged six to 11 years infected with the Hepatitis C virus (HCV), found that 99 % of children (n = 89/90) had undetectable levels of HCV - RNA 12 weeks after treatment.
As part of a compassionate use program, 104 post-liver transplant patients with recurring HCV who had exhausted all treatment options and had poor clinical prognoses, received sofosbuvir (SOF) and ribavirin (RBV) with pegylated interferon (PEG) included at the physicians» discretion for up to 48 weeks.
The results show that 12 weeks of DCV - SOF is a highly effective and well - tolerated treatment regimen for HCV in patients with HIV co-infection, including cirrhotic patients.
a b c d e f g h i j k l m n o p q r s t u v w x y z